Roberts Brandi
Insider CIK 1516354 · ANX Chief Financial Officer & SVP · RVA:AX SVP & Chief Financial Officer · TFFP Director · DFTX Chief Financial Officer · LBPH Executive VP and CFO · BTX CFO & SVP, Finance
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| DFTX Definium Therapeutics, Inc | S Sale | 2026-09-25 | 2026-09-29 | 3,377 | $36.57 | $123.5K | 394,528 | SEC↗ |
| DFTX Definium Therapeutics, Inc | S Sale | 2026-09-25 | 2026-09-29 | 3,377 | $36.57 | $123.5K | 394,528 | SEC↗ |
| DFTX Definium Therapeutics, Inc | A Award | 2026-09-14 | 2026-09-14 | 125,000 | — | $0 | 397,905 | SEC↗ |
| DFTX Definium Therapeutics, Inc | A Award | 2026-09-14 | 2026-09-14 | 125,000 | — | $0 | 397,905 | SEC↗ |
| DFTX Definium Therapeutics, Inc | A Award | 2026-08-12 | 2026-08-12 | 62,500 | — | $0 | 271,987 | SEC↗ |
| DFTX Definium Therapeutics, Inc | A Award | 2026-08-12 | 2026-08-12 | 62,500 | — | $0 | 271,987 | SEC↗ |
| DFTX Definium Therapeutics, Inc | S Sale | 2026-06-25 | 2026-06-26 | 3,013 | $45.03 | $135.7K | 209,487 | SEC↗ |
| DFTX Definium Therapeutics, Inc | A Award | 2026-06-22 | 2026-06-22 | 62,500 | — | $0 | 212,500 | SEC↗ |
| DFTX Definium Therapeutics, Inc | A Award | 2026-02-03 | 2026-02-05 | 150,000 | — | $0 | 150,000 | SEC↗ |
| MNMD Mind Medicine (MindMed) In | A Award deriv | 2025-06-02 | 2025-06-02 | 500,000 | — | $0 | 500,000 | SEC↗ |
| LBPH Longboard Pharmaceuticals, | D To issuer deriv | 2024-12-02 | 2024-12-02 | 15,090 | — | $0 | 0 | SEC↗ |
| LBPH Longboard Pharmaceuticals, | D To issuer deriv | 2024-12-02 | 2024-12-02 | 90,580 | — | $0 | 0 | SEC↗ |
| LBPH Longboard Pharmaceuticals, | D To issuer deriv | 2024-12-02 | 2024-12-02 | 119,700 | — | $0 | 0 | SEC↗ |
| LBPH Longboard Pharmaceuticals, | D To issuer deriv | 2024-12-02 | 2024-12-02 | 90,000 | — | $0 | 0 | SEC↗ |
| LBPH Longboard Pharmaceuticals, | D To issuer deriv | 2024-12-02 | 2024-12-02 | 139,380 | — | $0 | 0 | SEC↗ |
| LBPH Longboard Pharmaceuticals, | D To issuer deriv | 2024-12-02 | 2024-12-02 | 7,900 | — | $0 | 0 | SEC↗ |
| LBPH Longboard Pharmaceuticals, | A Award deriv | 2024-10-25 | 2024-10-29 | 7,900 | — | $0 | 7,900 | SEC↗ |
| TFFP TFF Pharmaceuticals, Inc. | A Award deriv | 2024-07-03 | 2024-07-08 | 3,165 | — | $0 | 3,165 | SEC↗ |
| TFFP TFF Pharmaceuticals, Inc. | A Award | 2024-07-03 | 2024-07-08 | 3,165 | — | $0 | 23,165 | SEC↗ |
| TFFP TFF Pharmaceuticals, Inc. | A Award deriv | 2024-04-18 | 2024-04-22 | 5,333 | — | $0 | 5,333 | SEC↗ |
| LBPH Longboard Pharmaceuticals, | A Award deriv | 2024-02-08 | 2024-02-09 | 90,580 | — | $0 | 90,580 | SEC↗ |
| LBPH Longboard Pharmaceuticals, | A Award | 2024-02-08 | 2024-02-09 | 15,090 | — | $0 | 15,090 | SEC↗ |
| TFFP TFF Pharmaceuticals, Inc. | A Award deriv | 2023-12-01 | 2023-12-04 | 52,858 | — | $0 | 52,858 | SEC↗ |
| TFFP TFF Pharmaceuticals, Inc. | P Buy | 2023-08-15 | 2023-08-15 | 20,000 | $0.25 | $5.0K | 20,000 | SEC↗ |
| LBPH Longboard Pharmaceuticals, | A Award deriv | 2023-02-09 | 2023-02-10 | 119,700 | — | $0 | 119,700 | SEC↗ |
| TFFP TFF Pharmaceuticals, Inc. | A Award deriv | 2022-12-29 | 2022-12-30 | 20,968 | — | $0 | 20,968 | SEC↗ |
| LBPH Longboard Pharmaceuticals, | A Award deriv | 2022-02-09 | 2022-02-11 | 90,000 | — | $0 | 90,000 | SEC↗ |
| LCTX Lineage Cell Therapeutics, | A Award deriv | 2020-03-17 | 2020-03-19 | 616,700 | — | $0 | 616,700 | SEC↗ |
| LCTX Lineage Cell Therapeutics, | P Buy | 2019-08-13 | 2019-08-15 | 5,000 | $1.01 | $5.0K | 5,000 | SEC↗ |
| BTX BIOTIME INC | A Award deriv | 2019-06-30 | 2019-07-02 | 150,000 | — | $0 | 150,000 | SEC↗ |
| BTX BIOTIME INC | A Award deriv | 2019-01-07 | 2019-01-09 | 500,000 | — | $0 | 500,000 | SEC↗ |
| RVA.AX REVA Medical, Inc. | P Buy | 2018-06-29 | 2018-07-02 | 4,908 | $1.53 | $7.5K | 54,908 | SEC↗ |
| RVA.AX REVA Medical, Inc. | A Award deriv | 2018-01-22 | 2018-01-23 | 100,000 | — | $0 | 100,000 | SEC↗ |
| RVA.AX REVA Medical, Inc. | A Award | 2018-01-22 | 2018-01-23 | 50,000 | — | $0 | 50,000 | SEC↗ |
| RVA:AX REVA Medical, Inc. | A Award deriv | 2017-09-18 | 2017-09-19 | 190,000 | — | $0 | 190,000 | SEC↗ |
| MSTX Mast Therapeutics, Inc. | A Award deriv | 2017-01-20 | 2017-01-23 | 889,926 | — | $0 | 889,926 | SEC↗ |
| MSTX Mast Therapeutics, Inc. | A Award deriv | 2016-01-04 | 2016-01-06 | 572,700 | — | $0 | 572,700 | SEC↗ |
| MSTX Mast Therapeutics, Inc. | A Award deriv | 2015-06-11 | 2015-06-12 | 444,400 | — | $0 | 444,400 | SEC↗ |
| MSTX Mast Therapeutics, Inc. | P Buy | 2015-03-27 | 2015-03-30 | 18,000 | $0.50 | $9.0K | 38,000 | SEC↗ |
| MSTX Mast Therapeutics, Inc. | P Buy | 2015-03-26 | 2015-03-30 | 20,000 | $0.50 | $10.0K | 20,000 | SEC↗ |
| MSTX Mast Therapeutics, Inc. | A Award deriv | 2015-01-02 | 2015-01-02 | 722,800 | — | $0 | 722,800 | SEC↗ |
| MSTX Mast Therapeutics, Inc. | A Award deriv | 2014-06-19 | 2014-06-20 | 336,600 | — | $0 | 336,600 | SEC↗ |
| MSTX Mast Therapeutics, Inc. | A Award deriv | 2014-01-02 | 2014-01-03 | 101,200 | — | $0 | 101,200 | SEC↗ |
| MSTX Mast Therapeutics, Inc. | A Award deriv | 2013-06-19 | 2013-06-21 | 301,250 | — | $0 | 301,250 | SEC↗ |
| ANX ADVENTRX PHARMACEUTICALS I | A Award deriv | 2013-01-02 | 2013-01-03 | 75,750 | — | $0 | 75,750 | SEC↗ |